The invention discloses the excess proliferative disease that is used for the treatment of in the mammal such as the mek inhibitor of cancer and inflammation and inflammatory disease.The invention also discloses the method for using the excess proliferative disease in such compounds for treating mammal and the pharmaceutical composition that comprises such chemical compound.